Pharmafile Logo
Pharmafocus logo
Advanced Search

Vertex

Showing 10 posts of 40 posts found.

Incivek image

Vertex ditches its once-stellar hep C drug

August 14, 2014
Sales and Marketing Gilead, Incivek, Vertex, hep C, sovaldi

Vertex will stop selling its once-blockbuster hepatitis C drug in the US this autumn after being crushed by new therapies. …

News
janssen image

Janssen and GSK in hep C tie-ups

November 8, 2012
Research and Development, Sales and Marketing GSK, Janssen, Vertex, hep C

Janssen and GlaxoSmithKline are to conduct separate Phase II studies with Vertex Pharmaceuticals to test an investigational all-oral regimen to …

News

Vertex abandons hep C drug

September 27, 2012
Research and Development, Sales and Marketing Alios BioPharma, Vertex, hep C

Vertex Pharmaceutical’s pipeline has been dealt a blow with the abandonment of an investigational hepatitis C compound. The US firm, …

News

Vertex admits blunder over drug data

May 31, 2012
Sales and Marketing Kalydeco, Kalydeco., Vertex, cystic fibrosis

Vertex has been embarrassed after it released claims for its pipeline drug VX-809 which turned out to be incorrect. The …

News

Landmark CF treatment set for European approval

May 30, 2012
Sales and Marketing CHMP, Europe, Kalydeco, Vertex, cystic fibrosis

A European committee is recommending the approval of Vertex’s first-in-class treatment for cystic fibrosis.  Kalydeco (ivacaftor) is a landmark in …

News

Groundbreaking CF drug recommended in Europe

May 25, 2012
Sales and Marketing CHMP, EMA, Kalydeco, Vertex, cystic fibrosis

The first-in-class treatment for cystic fibrosis Kalydeco has been recommended by the EMA’s medicines committee. Kalydeco (ivacaftor) promises to be …

News

Kalydeco to be landmark in cystic fibrosis treatment

February 1, 2012
Vertex, cystic fibrosis, telaprevir

Vertex’s first-in-class treatment for cystic fibrosis Kalydeco has been approved by the FDA. The approval is a landmark in the …

News

Vertex chief to step down; names Jeffrey Leiden as new leader

December 19, 2011
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Abbott, Vertex

Vertex has named a new chief executive to succeed Matthew Emmens, who will retire early next year. He will be …

Appointment

J&J and Vertex’s hep C drug Incivek approved by FDA

May 24, 2011
Sales and Marketing FDA, Incivek, Johnson & Johnson, Vertex, hepatitis C, telaprevir

The FDA has approved Johnson & Johnson/Vertex’s new oral hepatitis C drug Incivek. Incivek (telaprevir), a protease inhibitor, is now …

News

Vertex’s cystic fibrosis drug shows huge promise

February 28, 2011
Research and Development, Sales and Marketing VX-770, Vertex, cystic fibrosis

US pharma company Vertex has announced extremely promising results for a drug that could be a major advance in treating …

News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026